Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the upcoming investor conference, detailed below.
-
Leerink Partners Global Biopharma Conference 2024
Event Date: March 11-13, 2024, Miami, Florida
| Press Release in English | 125.83 KB |
| Communiqué de presse en français | 97.06 KB |